1. Home
  2. UBCP vs PSTV Comparison

UBCP vs PSTV Comparison

Compare UBCP & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UBCP

United Bancorp Inc.

N/A

Current Price

$13.85

Market Cap

78.4M

Sector

Finance

ML Signal

N/A

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$0.28

Market Cap

80.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBCP
PSTV
Founded
1902
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.4M
80.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UBCP
PSTV
Price
$13.85
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.00
AVG Volume (30 Days)
4.3K
11.0M
Earning Date
02-06-2026
10-30-2025
Dividend Yield
6.88%
N/A
EPS Growth
N/A
N/A
EPS
1.31
N/A
Revenue
$30,516,000.00
$5,258,000.00
Revenue This Year
N/A
$1.73
Revenue Next Year
$5.59
$12.05
P/E Ratio
$10.37
N/A
Revenue Growth
4.40
N/A
52 Week Low
$12.25
$0.16
52 Week High
$15.64
$2.31

Technical Indicators

Market Signals
Indicator
UBCP
PSTV
Relative Strength Index (RSI) 48.00 25.61
Support Level $13.55 $0.26
Resistance Level $13.98 $0.31
Average True Range (ATR) 0.35 0.04
MACD -0.11 -0.03
Stochastic Oscillator 31.02 7.63

Price Performance

Historical Comparison
UBCP
PSTV

About UBCP United Bancorp Inc.

United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: